ARQT
Price
$10.44
Change
+$0.04 (+0.38%)
Updated
Nov 8, 03:15 PM (EDT)
116 days until earnings call
BEAM
Price
$26.86
Change
+$0.76 (+2.91%)
Updated
Nov 8, 04:05 PM (EDT)
116 days until earnings call
Ad is loading...

ARQT vs BEAM

Header iconARQT vs BEAM Comparison
Open Charts ARQT vs BEAMBanner chart's image
Arcutis Biotherapeutics
Price$10.44
Change+$0.04 (+0.38%)
Volume$2.15K
CapitalizationN/A
Beam Therapeutics
Price$26.86
Change+$0.76 (+2.91%)
Volume$2.53K
CapitalizationN/A
View a ticker or compare two or three
ARQT vs BEAM Comparison Chart
Loading...
ARQT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ARQT vs. BEAM commentary
Nov 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARQT is a Buy and BEAM is a StrongBuy.

COMPARISON
Comparison
Nov 08, 2024
Stock price -- (ARQT: $10.40 vs. BEAM: $26.09)
Brand notoriety: ARQT and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARQT: 249% vs. BEAM: 87%
Market capitalization -- ARQT: $1.16B vs. BEAM: $2.16B
ARQT [@Biotechnology] is valued at $1.16B. BEAM’s [@Biotechnology] market capitalization is $2.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARQT’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ARQT’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ARQT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARQT’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • ARQT’s TA Score: 4 bullish, 6 bearish.
  • BEAM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ARQT.

Price Growth

ARQT (@Biotechnology) experienced а +25.15% price change this week, while BEAM (@Biotechnology) price change was +19.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.42%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +11.55%.

Reported Earning Dates

ARQT is expected to report earnings on Mar 04, 2025.

BEAM is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+3.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.16B) has a higher market cap than ARQT($1.16B). ARQT YTD gains are higher at: 221.981 vs. BEAM (-4.148). BEAM (-162.88M) and ARQT (-163.56M) have comparable annual earnings (EBITDA) . BEAM has more cash in the bank: 1.01B vs. ARQT (362M). BEAM has less debt than ARQT: BEAM (165M) vs ARQT (208M). BEAM has higher revenues than ARQT: BEAM (353M) vs ARQT (132M).
ARQTBEAMARQT / BEAM
Capitalization1.16B2.16B54%
EBITDA-163.56M-162.88M100%
Gain YTD221.981-4.148-5,352%
P/E RatioN/AN/A-
Revenue132M353M37%
Total Cash362M1.01B36%
Total Debt208M165M126%
TECHNICAL ANALYSIS
Technical Analysis
ARQTBEAM
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ARQT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIESX25.340.33
+1.32%
Calvert International Equity R6
JENIX66.680.78
+1.18%
Jensen Quality Growth I
JERAX12.110.10
+0.83%
Janus Henderson Global Real Estate A
FARMX18.27N/A
N/A
Fidelity Agricultural Productivity
VGRIX83.08-0.43
-0.51%
JPMorgan US Value A

ARQT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARQT has been loosely correlated with SANA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ARQT jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARQT
1D Price
Change %
ARQT100%
+7.66%
SANA - ARQT
39%
Loosely correlated
-9.09%
BEAM - ARQT
38%
Loosely correlated
-1.99%
SWTX - ARQT
38%
Loosely correlated
+0.27%
OCUL - ARQT
37%
Loosely correlated
-1.46%
ARWR - ARQT
37%
Loosely correlated
+0.23%
More